Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 35, 2985-2990, November 1, 1975]
© 1975 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Whitehead, V. M.
Right arrow Articles by Stelcner, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Whitehead, V. M.
Right arrow Articles by Stelcner, S.

Tissue-specific Synthesis of Methotrexate Polyglutamates in the Rat1

V. Michael Whitehead2, Marlene M. Perrault and Susan Stelcner

Research Institute, Montreal General Hospital, Montreal, Quebec, Canada

2 To whom reprint requests should be addressed, at Division of Haematology, Montreal General Hospital, 1650 Cedar Avenue, Montreal, Quebec, Canada.

Purified tritium-labeled methotrexate was administered to rats and Sephadex G-15 gel chromatography was used to study the formation of poly-{gamma}-glutamyl metabolites of methotrexate in different tissues. These metabolites were recognized as tritium-labeled antifolate fractions and were identified by their response to serum pteroylpolyglutamate hydrolases and by cochromatography with authentic standards. After doses equivalent to 15 to 20 mg for man, rat liver and kidney were found to contain both 4-amino-10-methylpteroylglutamyl-{gamma}-glutamic acid and 4-amino-10-methylpteroylglutamyl-{gamma}-glutamyl-{gamma}-glutamic acid. With one-third of the dose, only 4-amino-10-methylpteroylglutamyl-{gamma}-glutamic acid was found. Synthesis of methotrexate polyglutamates in liver and kidney was limited to the interval immediately following methotrexate administration and appeared to occur by sequential addition of single glutamyl residues to so-called "free" intracellular methotrexate. No synthesis of methotrexate polyglutamates was demonstrated in small intestine or thymus. After formation, 4-amino-10-methylpteroyglutamyl-{gamma}-glutamic acid disappeared from liver and kidney with a half-time of 6.5 days. The effect of these metabolites of methotrexate on cell metabolism is unknown.

1 This work was supported by Grant MA-2384 from the Medical Research Council of Canada and by a grant from the Cancer Research Society, Inc.

Received 5/31/74. Accepted 7/16/75.




This article has been cited by other articles:


Home page
Cancer Res.Home page
H. Zeng, Z.-S. Chen, M. G. Belinsky, P. A. Rea, and G. D. Kruh
Transport of Methotrexate (MTX) and Folates by Multidrug Resistance Protein (MRP) 3 and MRP1: Effect of Polyglutamylation on MTX Transport
Cancer Res., October 1, 2001; 61(19): 7225 - 7232.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1975 by the American Association for Cancer Research.